Acrotech Biopharma Inc.

This study compares two new drug combinations against standard chemotherapy for people newly diagnosed with peripheral T-cell lymphoma, a rare and aggressive blood cancer. Researchers want to see if adding either belinostat or pralatrexate to chemotherapy helps patients live long…

This early-stage study aims to understand how the cancer drug pralatrexate is processed by the body in people with varying degrees of liver impairment. It will involve about 24 adults with advanced solid tumors or blood cancers. The main goal is to measure drug levels in the bloo…